Literature DB >> 1279204

Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4.

G Larralde1, M Gorziglia.   

Abstract

Three cDNA clones comprising the VP8 subunit of the VP4 of human rotavirus strain KU (VP7 serotype G1; VP4 serotype P1A) G1 were constructed. The corresponding encoded peptides were designated according to their locations in the VP8 subunit as A (amino acids 1 to 102), B (amino acids 84 to 180), and C (amino acids 150 to 246 plus amino acids 247 to 251 from VP5). In addition, cDNA clones encoding peptide B of the VP8 subunit of the VP4 gene from human rotavirus strains DS-1 (G2; P1B) and 1076 (G2; P2) were also constructed. These DNA fragments were inserted into plasmid pGEMEX-1 and expressed in Escherichia coli. Western immunoblot analysis using antisera to rotavirus strains KU (P1A), Wa (P1A), DS-1 (P1B), 1076 (P2), and M37 (P2) demonstrated that peptides A and C cross-reacted with heterotypic human rotavirus VP4 antisera, suggesting that these two peptides represent conserved epitopes in the VP8 subunit. In contrast, peptide B appears to be involved in the VP4 serotype and subtype specificities, because it reacted only with the corresponding serotype- and subtype-specific antiserum. Antiserum raised against peptide A, B, or C of strain KU contained a lower level of neutralizing activity than did that induced by the entire VP8 subunit. In addition, the serotype-specific neutralizing activity of anti-KU VP8 serum was ablated after adsorption with the KU VP8 protein but not with a mixture of peptides A, B, and C of strain KU, suggesting that most of the serotype-specific epitopes in the VP8 subunit are conformational and are dependent on the entire amino acid sequence of VP8.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279204      PMCID: PMC240451          DOI: 10.1128/JVI.66.12.7438-7443.1992

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites.

Authors:  E R Mackow; M Y Yamanaka; M N Dang; H B Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections.

Authors:  M Gorziglia; K Green; K Nishikawa; K Taniguchi; R Jones; A Z Kapikian; R M Chanock
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

3.  Three-dimensional structure of rotavirus.

Authors:  B V Prasad; G J Wang; J P Clerx; W Chiu
Journal:  J Mol Biol       Date:  1988-01-20       Impact factor: 5.469

4.  Identification of the two rotavirus genes determining neutralization specificities.

Authors:  P A Offit; G Blavat
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.

Authors:  M Gorziglia; G Larralde; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection.

Authors:  M Gorziglia; Y Hoshino; A Buckler-White; I Blumentals; R Glass; J Flores; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

8.  Human rotavirus strain 69M has a unique VP4 as determined by amino acid sequence analysis.

Authors:  Y Qian; K Y Green
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

9.  Sequential passages of human rotavirus in MA-104 cells.

Authors:  T Urasawa; S Urasawa; K Taniguchi
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

10.  Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization.

Authors:  Y Hoshino; R G Wyatt; H B Greenberg; J Flores; A Z Kapikian
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

View more
  12 in total

1.  Norovirus P particle, a novel platform for vaccine development and antibody production.

Authors:  Ming Tan; Pengwei Huang; Ming Xia; Ping-An Fang; Weiming Zhong; Monica McNeal; Chao Wei; Wen Jiang; Xi Jiang
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  Identification of group A porcine rotavirus strains bearing a novel VP4 (P) Genotype in Italian swine herds.

Authors:  V Martella; M Ciarlet; K Bányai; E Lorusso; S Arista; A Lavazza; G Pezzotti; N Decaro; A Cavalli; M S Lucente; M Corrente; G Elia; M Camero; M Tempesta; C Buonavoglia
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

3.  Sequence conservation within neutralization epitope regions of VP7 and VP4 proteins of human serotype G4 rotavirus isolates.

Authors:  E A Palombo; R F Bishop; R G Cotton
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Nucleotide sequence and expression in E. coli of the complete P4 type VP4 from a G2 serotype human rotavirus.

Authors:  N P Mahajan; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus.

Authors:  Khadijeh Nasiri; Mohammadreza Nassiri; Mojtaba Tahmoorespur; Alireza Haghparast; Saeed Zibaee
Journal:  Adv Pharm Bull       Date:  2016-03-17

6.  Serological and genomic characterisation of group A rotaviruses from lambs.

Authors:  T A Fitzgerald; M Munoz; A R Wood; D R Snodgrass
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Identification of a G2-like porcine rotavirus bearing a novel VP4 type, P[32].

Authors:  Patrick J Collins; Vito Martella; Canio Buonavoglia; Helen O'Shea
Journal:  Vet Res       Date:  2010-07-29       Impact factor: 3.683

9.  Determination of human rotavirus VP4 using serotype-specific cDNA probes.

Authors:  N B Rasool; G Larralde; M I Gorziglia
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Human rotavirus K8 strain represents a new VP4 serotype.

Authors:  B Li; G Larralde; M Gorziglia
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.